Kite Pharma, Inc. — Net Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8d92d7b4-d26a-4cdd-8039-47077c8493b0/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2016 | $-267.1M | 2016-01-01 – 2016-12-31 | evidence 0001510580-17-000003 |
| FY 2015 | $-101.7M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-013699 |
| FY 2014 | $-42.6M | 2014-01-01 – 2014-12-31 | evidence 0001564590-15-001985 |
| FY 2013 | $-6.4M | 2013-01-01 – 2013-12-31 | evidence 0001564590-15-001985 |
| FY 2012 | $-2.6M | 2012-01-01 – 2012-12-31 | evidence 0001564590-15-001985 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).